Bausch Health Companies Inc. financial data

Symbol
BHC on NYSE
Industry
Pharmaceutical Preparations
Location
2150 St. Elzear Blvd. West, Laval, Quebec, Quebec, Canada
State of incorporation
New Jersey
Fiscal year end
December 31
Former names
Valeant Pharmaceuticals International, Inc. (to 7/3/2018), BIOVAIL Corp (to 9/27/2010), BIOVAIL CORP INTERNATIONAL (to 4/7/2010), BIOVAIL CORPORATION INTERNATIONAL (to 1/5/2001)
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 121 % +13.1%
Quick Ratio 33.7 % +26.6%
Debt-to-equity -2.69 K % +30.3%
Return On Equity 827 %
Return On Assets -1.7 % -25.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 367 M shares +0.85%
Common Stock, Shares, Outstanding 367 M shares +0.84%
Entity Public Float 2.42 B USD -3.53%
Common Stock, Value, Issued 10.5 B USD +0.72%
Weighted Average Number of Shares Outstanding, Basic 367 M shares +0.96%
Weighted Average Number of Shares Outstanding, Diluted 367 M shares +0.96%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 8.97 B USD +10%
Costs and Expenses 7.9 B USD +1.17%
Operating Income (Loss) 1.07 B USD +211%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -323 M USD -76.5%
Income Tax Expense (Benefit) 156 M USD -9.3%
Net Income (Loss) Attributable to Parent -455 M USD -27.5%
Earnings Per Share, Basic -1.24 USD/shares -26.5%
Earnings Per Share, Diluted -1.24 USD/shares -26.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 733 M USD +41.5%
Inventory, Net 1.64 B USD +33.9%
Assets, Current 5.4 B USD +27.4%
Deferred Income Tax Assets, Net 2.15 B USD -0.65%
Property, Plant and Equipment, Net 1.71 B USD +7.33%
Operating Lease, Right-of-Use Asset 185 M USD -16.3%
Intangible Assets, Net (Excluding Goodwill) 6.18 B USD +11.4%
Goodwill 11.2 B USD -3.62%
Other Assets, Noncurrent 312 M USD -1.89%
Assets 26.9 B USD +5.77%
Accounts Payable, Current 642 M USD +14.4%
Accrued Liabilities, Current 3.23 B USD +10.6%
Liabilities, Current 4.41 B USD +12.3%
Deferred Income Tax Liabilities, Net 170 M USD -17.1%
Operating Lease, Liability, Noncurrent 148 M USD -19.6%
Other Liabilities, Noncurrent 751 M USD +0.67%
Liabilities 27.1 B USD +7.06%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.92 B USD +3.62%
Retained Earnings (Accumulated Deficit) -9.84 B USD -4.85%
Stockholders' Equity Attributable to Parent -1.12 B USD -39.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -174 M USD -220%
Liabilities and Equity 26.9 B USD +5.77%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 211 M USD +37%
Net Cash Provided by (Used in) Financing Activities -340 M USD -139%
Net Cash Provided by (Used in) Investing Activities -73 M USD +6.41%
Common Stock, Shares, Issued 367 M shares +0.84%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -207 M USD -245%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 755 M USD +42.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.53 B USD -0.46%
Deferred Tax Assets, Valuation Allowance 2.29 B USD +14.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.27 pure 0%
Deferred Tax Assets, Gross 4.55 B USD +4%
Operating Lease, Liability 209 M USD -10.7%
Depreciation 187 M USD +4.47%
Payments to Acquire Property, Plant, and Equipment 82 M USD +74.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -383 M USD +24.8%
Lessee, Operating Lease, Liability, to be Paid 251 M USD -12.5%
Property, Plant and Equipment, Gross 3.79 B USD +7.67%
Operating Lease, Liability, Current 61 M USD +22%
Lessee, Operating Lease, Liability, to be Paid, Year Two 54 M USD +10.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 74 M USD +17.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +15.4%
Deferred Income Tax Expense (Benefit) 6 M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 42 M USD -20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 35 M USD -16.7%
Deferred Federal Income Tax Expense (Benefit) 21 M USD
Current Income Tax Expense (Benefit) 215 M USD -20.7%
Unrecognized Tax Benefits 918 M USD +4.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 29 M USD -19.4%
Operating Lease, Payments 73 M USD +4.29%
Current Federal Tax Expense (Benefit) 21 M USD +40%
Deferred Tax Assets, Net of Valuation Allowance 2.3 B USD -2.38%
Share-based Payment Arrangement, Expense 33 M USD -19.5%